Atlas Trials

University of Oslo School of Pharmacy

18 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch University of Oslo School of Pharmacy

RecordFirmDate
Computer Guided Doing of Tacrolimus in Renal Transplantation (NCT02010320)University of Oslo School of Pharmacy2014-01-01
Generic Tacrolimus in the Elderly - Prograf® vs Tacni® (NCT01698541)University of Oslo School of Pharmacy2013-02-01
The Rosuvastatin In TrAnsplant Recipients Study (NCT01524601)University of Oslo School of Pharmacy2012-02-01
Insulin Secretion and Advagraf (NCT01092806)University of Oslo School of Pharmacy2009-10-01
Sitagliptin in Renal Transplant Recipients (NCT00740363)University of Oslo School of Pharmacy2008-09-01
Interaction Between Rimonabant and Cyclosporine and Tacrolimus (NCT00525681)University of Oslo School of Pharmacy2007-09-01
Investigations on the Influence of Bariatric Surgery on the Metabolism and Absorption of Atorvastatin (NCT00331565)University of Oslo School of Pharmacy2006-08-01
Metabolic Pattern of Cyclosporine A and Acute Renal Failure (NCT00264355)University of Oslo School of Pharmacy2005-12-01
Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy (NCT00264368)University of Oslo School of Pharmacy2005-12-01
Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation (NCT00139009)University of Oslo School of Pharmacy2005-06-01
Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity (NCT00414531)University of Oslo School of Pharmacy2005-05-01
Effects of Cyclosporine A on Pancreatic Insulin Secretion (NCT00139035)University of Oslo School of Pharmacy2005-04-01
Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity (NCT00120055)University of Oslo School of Pharmacy2005-02-01
Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant (NCT00148252)University of Oslo School of Pharmacy2003-02-01
Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients (NCT00319189)University of Oslo School of Pharmacy2002-11-01
Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk (NCT00138970)University of Oslo School of Pharmacy2002-01-01
Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis (NCT00222534)University of Oslo School of Pharmacy2002-01-01
Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery (NCT00244530)University of Oslo School of Pharmacy2001-06-01

Track University of Oslo School of Pharmacy automatically

Every clearance here is in the API, with alerts when new ones post.